Byrne Asset Management’s Novo Nordisk NVO Stock Holding History

Byrne Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Hold	2,785	–	–	0.07%	206
2026 Q1	$102K	Sell	2,785 -817	-23%	-$38.7K	0.06%	222
2025 Q4	$183K	Buy	+3,602	New	+$184K	0.1%	141
2025 Q3	–	Hold	0	–	–	–	116
2025 Q2	–	Sell	-3,802	Closed	-$259K	–	96
2025 Q1	$264K	Sell	3,802 -365	-9%	-$30.1K	0.19%	95
2024 Q4	$358K	Sell	4,167 -193	-4%	-$20.9K	0.25%	75
2024 Q3	$519K	Buy	+4,360	New	+$581K	0.35%	69
2024 Q2	–	Sell	-4,837	Closed	-$641K	–	65
2024 Q1	$621K	Buy	4,837 +27	+0.6%	+$3.21K	0.43%	67
2023 Q4	$499K	Sell	4,810 -78	-2%	-$7.71K	0.38%	71
2023 Q3	$445K	Hold	4,888	–	–	0.37%	71
2023 Q2	$396K	Sell	4,888 -190	-4%	-$15.5K	0.26%	102
2023 Q1	$404K	Buy	5,078 +38	+0.8%	+$2.69K	0.29%	97
2022 Q4	$341K	Sell	5,040 -660	-12%	-$38.7K	0.25%	101
2022 Q3	$284K	Hold	5,700	–	–	0.22%	101
2022 Q2	$318K	Sell	5,700 -200	-3%	-$11.1K	0.23%	86
2022 Q1	$328K	Hold	5,900	–	–	0.2%	91
2021 Q4	$330K	Buy	+5,900	New	+$320K	0.21%	92

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Byrne Asset Management's NVO Position: Q2 2026 in Review

Byrne Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 2,785 shares worth $134K. The position accounts for 0.07% of the portfolio, ranked #206.

Byrne Asset Management first reported a position in NVO in Q4 2021 and has held it in 16 quarters since. The position peaked at $621K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Byrne Asset Management held 2,785 shares of Novo Nordisk worth $134K as of Q2 2026.
Byrne Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.07% of Byrne Asset Management's portfolio in Q2 2026, its #206 holding.
Byrne Asset Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 16 quarters since.
Byrne Asset Management's Novo Nordisk position peaked at $621K in Q1 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.